ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00516373
Recruitment Status : Active, not recruiting
First Posted : August 15, 2007
Last Update Posted : February 28, 2018
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : December 17, 2008
  Estimated Study Completion Date : December 28, 2018
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):